“The move comes after Shkreli, its former CEO, was charged on December 17 in federal court with securities fraud related to a hedge fund and another company. Shkreli pleaded not guilty to the charges. Shkreli initially gained notoriety in September when, as the chief executive of Turing Pharmaceuticals, he raised the price of Daraprim— a drug used to treat a dangerous parasitic infection— from $13.50 to $750 per pill. The move generated harsh criticism from prominent politicians, including Hillary Clinton, and spurred a senate investigation into drug pricing.”
http://www.nydailynews.com/news/national/martin-shkreli-company-files-bankruptcy-article-1.2481147
Related posts:
Obama moves towards sending military weapons to Somalia
Bitcoin vault offering insurance is 'world's first'
U.S. to open military ties soon with Myanmar: official
What Really Drove the Children North
Bitcoin Network Is Here to Stay - Montreal Economic Institute
Americans pile into silver, gold coins
American anti-virus mogul McAfee warns Canadians about government spying
Nearly Every Major Federal Agency Has Reduced Projected Furloughs
How Do You Mine for Bitcoins?
Public Approval of Supreme Court Falls to All-Time Low
Ukip wins European elections with ease to set off political earthquake
Wegelin chief takes blame for oldest Swiss bank's collapse over U.S. taxes
China produces as much CO2 per person as Europe
Spy-spotter: joke about scary visit came true
$1.3 billion flowing through 2012 presidential race